Article metrics

Download PDFPDF

584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies

 

Online download statistics by month:

Online download statistics by month: November 2023 to September 2024

AbstractFullPdf
Nov 2023194012
Dec 20235107
Jan 20249208
Feb 20245204
Mar 20245402
Apr 20244402
May 20245407
Jun 20245403
Jul 20246605
Aug 20243402
Sep 20243301
Total728053